Advanced Oncotherapy (AVO) today said it could receive the initial tranche of funding from its recapitalisation plan this month. Following ‘unexpected delays’ with its third-party…
Advanced Oncotherapy recapitalisation delayed
About LaingBuisson
LaingBuisson has been serving clients for over 30 years with insights, analysis and data on market structures, policy and strategy across healthcare, social care and education.
Contact us: [email protected]
Follow LaingBuisson
©2024 All rights reserved LaingBuisson 
 today said it could receive the initial tranche of funding from its recapitalisation plan this month.){kind=link}